Aryl Hydrocarbon Receptor-Mediated Inhibition of Osteogenesis in a Teleost Model In Vivo and Human Mesenchymal Stromal Cells In Vitro.
Year: 2017
Type: article
Abstract: Bone formation and homeostasis is a well-orchestrated process governed by multiple developmental pathways integrating endogenous and exogenous stimuli.Perturbations in these pathways are linked to skeletal dysplasias (e.g.osteogenesis imperfecta) and adult degenerative bone diseases (e.g.osteoporosis); however, there is increasing concern that xenobiotic exposure may perturb the regulatory networks that direct osteogenic differentiation from multipotent mesenchymal stem cells.While numerous studies have identified bone as a sensitive target of aryl hydrocarbon receptor (AhR) ligand exposure, we hypothesized that ligand-activated AhR primarily impacts bone formation through inhibition of osteogenic differentiation from mesenchymal stem cell progenitors.To test this hypothesis, we utilized Japanese medaka in vivo and human bone-derived mesenchymal stromal cells in vitro.First, we assessed how embryonic exposure to TCDD impacts osteogenesis in Japanese medaka (Oryzias latipes).Embryos from inbred wild-type Orange-red Hd-dR and transgenic medaka tg(twist:EGFP, osx/sp7:mCherry, col10a1:nlGFP) were exposed to 0.15 nM and 0.3 nM TCDD and reared until 20 dpf.Exposure to TCDD resulted in an overall attenuation of vertebral ossification, and effects on mineralization were consistent with modifications in cell number and cell localization of transgene-labeled osteoblast and osteoblast progenitor cells.Through a targeted and global gene expression analysis we observe attenuated expression of key osteogenic regulators (runx2, osx/sp7) and extracellular matrix genes (opn/spp1, col1, col10a1, and bglap/osc) at 20 dpf following TCDD exposure.Our data revealed enrichment of several genes within select pathological states including inflammatory disease, connective tissue disorders, and musculoskeletal disorders.In our next set of experiments, we investigated AhR-mediated osteogenic inhibition in human bone-derived mesenchymal stromal cells (hBMSCs) in vitro.Cells from three donors were assessed during early differentiation (3 days post induction, dpi), extracellular matrix synthesis (7 dpi), and apical matrix mineralization (14-17 dpi).In all donors we found a consistent TCDD-mediated attenuation of alkaline phosphatase (ALP) activity, matrix mineralization, and mRNA expression of transcriptional regulators (DLX5) and osteogenic markers (ALP, OPN, IBSP).FGFR ligands, FGF9 and FGF18, were upregulated suggesting that TCDD may influence pathways associated with maintaining stemness of hBMSCs.Relative to undifferentiated cells, expression of stemness/potency markers SOX2, OCT4, NANOG, and SALL4 was reduced in osteogenic controls while expression in TCDD-treated cells remained elevated and comparable to undifferentiated cells.Co-exposure with the AhR antagonist GNF351 partially rescued these effects, suggesting that AhR activation is mechanistically associated with TCDD-mediated inhibition of osteogenesis.Currently a global RNA-Seq analysis is underway to assess transcriptomic alterations during early (hours), intermediate (days), and apical (two and a half weeks post induction) stages of osteogenesis.Included in this assessment are GM/DMSO-(undifferentiated), ODM/DMSO-(differentiated), and ODM/TCDD-treated hBMSCs, which enables analysis of normal and AhR-inhibited osteogenesis.While this assessment remains in progress, we present preliminary data from three and seven days post induction demonstrating TCDD-mediated alterations in developmental signaling pathways (WNT, FGF, BMP/TGF-β), extracellular matrix genes markers, transcriptional regulators, and lncRNAs.Our assessment has currently identified numerous candidate epigenetic modulators, most notably SUV39H1/2, previously shown to impact post-translational modification of histones, chromatin remodeling, and mRNA transcription or translation.GM/DMSO and ODM/TCDD demonstrate similar patterns in genes associated with stemness phenotypes suggesting that epigenetic modulation may in fact play a significant role in MSC lineage determination.Our data from Japanese medaka and hBMSCs reveal that TCDD dysregulates bone formation through an overall attenuation of early osteogenic regulators, extracellular matrix genes, and matrix mineralization.We build upon prior studies that suggest a putative role for ligand-activated AhR in influencing skeletal dysplasias and adult bone diseases.Furthermore, we highlight the advantages of two alternative models to investigate xenobiotic-induced skeletal toxicity.
Author: AtLee T. D. Watson
Language: English
Topic: Bone Metabolism and Diseases
Subfield: Molecular Biology
Domain: Life Sciences
Keywords: aryl hydrocarbon receptor, TCDD, osteogenic differentiation, mesenchymal stem cells, bone formation, Japanese medaka, vertebral ossification, bone mineralization, extracellular matrix genes, Runx2, alkaline phosphatase, xenobiotic exposure, skeletal dysplasia, osteoporosis, gene expression profiling, alkaline phosphatase activity
Open Access status: green
OpenAlex ID: W2901628215
